We are live on ! Find out more
SIC

Starr International Company Portfolio holdings

AUM $19.9M
1-Year Est. Return 39.69%
This Fund
S&P 500
This Quarter Est. Return
-50.93%
1 Year Est. Return
-39.69%
3 Year Est. Return
-26.08%
5 Year Est. Return
-43.79%
10 Year Est. Return
-39.24%
AUM
$66.1M
AUM Growth
-$83.3M
Cap. Flow
+$148K
Cap. Flow %
0.22%
Top 10 Hldgs %
100%
Holding
3
New
Increased
1
Reduced
Closed

Top Buys

Rank Stock Value
1
BCSF icon
Bain Capital Specialty
BCSF
+$148K

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 78.66%
2 Financials 21.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CELU icon
1
Celularity
CELU
$21.7M
$52M 78.66%
1,528,139
BCSF icon
2
Bain Capital Specialty
BCSF
$802M
$11.1M 16.77%
813,811
+9,912
+1% +$148K
AIG icon
3
American International
AIG
$41.9B
$3.02M 4.57%
59,040

Similar funds

Starr International Company's Q2 2022 Portfolio in Review

As of Q2 2022, Starr International Company held 3 positions worth $66.1M, down 56% from $149M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q2 2022: portfolio turnover was 0%. Starr International Company opened no new positions and made no exits, leaving the 3-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 79% of assets, down from 89% a quarter earlier, followed by Financials.

  • Starr International Company added most to Bain Capital Specialty in Q2 2022, an estimated $148K increase.
  • Starr International Company's ten largest holdings make up 100% of its $66.1M portfolio in Q2 2022.
  • Starr International Company opened 0 new positions and closed 0 in Q2 2022.
  • Starr International Company's portfolio value fell 56% quarter-over-quarter to $66.1M.

Based on Starr International Company's 13F filing for Q2 2022, filed 12 Aug 2022.